HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Assortment of posthepatectomy hyperbilirubinemia by the occurring time with reference to indication of plasma exchange.

Abstract
This study was undertaken to assort the group of posthepatectomy hyperbilirubinemia by occurring time for helping elucidate its indication of plasma exchange (PE). PE was carried out for 14 cases among 198 hepatectomized patients. The 14 cases were classified for 3 groups due to the period between operation and PE. 1: Early type (less than 2 weeks), 2:Intermediate type (2 less than-less than 8 weeks), 3: Late type (greater than 8 weeks). The results were as follows. Number (liver cirrhosis (LC)) [table: see text]. The effect was expected for the early groups since PE would remove overload against the regenerating residual liver. However, there were no survival cases among the early group or LC group. These results suggest that PE may be effective for the slowly increasing hyperbilirubinemia in not cirrhotic patients and that the state of hyperbilirubinemia is the terminal stage for LC patients even under the particular situation such as posthepatectomy.
AuthorsS Kobayashi, Y Tabata, K Soeda, H Hayashi, H Hirasawa, M Odaka, K Isono
JournalBiomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology (Biomater Artif Cells Immobilization Biotechnol) Vol. 19 Issue 1 Pg. 213-8 ( 1991) ISSN: 1055-7172 [Print] United States
PMID1751672 (Publication Type: Journal Article)
Topics
  • Hepatectomy (adverse effects)
  • Humans
  • Hyperbilirubinemia (classification, etiology, therapy)
  • Liver Cirrhosis (surgery)
  • Plasma Exchange
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: